日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/05/17 | 7,760 | 7,900 | 7,740 | 7,870 | +200 | +2.6% | 225,300 |
| 2018/05/16 | 7,780 | 7,910 | 7,630 | 7,670 | -100 | -1.3% | 285,600 |
| 2018/05/15 | 7,990 | 8,090 | 7,750 | 7,770 | -120 | -1.5% | 337,600 |
| 2018/05/14 | 8,190 | 8,220 | 7,850 | 7,890 | -390 | -4.7% | 271,700 |
| 2018/05/11 | 7,940 | 8,360 | 7,940 | 8,280 | +450 | +5.7% | 490,600 |
| 2018/05/10 | 7,560 | 7,880 | 7,410 | 7,830 | +120 | +1.6% | 579,700 |
| 2018/05/09 | 7,670 | 7,730 | 7,600 | 7,710 | +50 | +0.7% | 276,800 |
| 2018/05/08 | 7,770 | 7,870 | 7,630 | 7,660 | -140 | -1.8% | 258,000 |
| 2018/05/07 | 7,840 | 7,930 | 7,690 | 7,800 | +20 | +0.3% | 216,200 |
| 2018/05/02 | 7,710 | 7,820 | 7,560 | 7,780 | +50 | +0.6% | 418,500 |
| 2018/05/01 | 8,060 | 8,060 | 7,670 | 7,730 | -430 | -5.3% | 412,600 |
| 2018/04/27 | 7,990 | 8,170 | 7,920 | 8,160 | +320 | +4.1% | 320,500 |
| 2018/04/26 | 7,790 | 7,870 | 7,760 | 7,840 | -190 | -2.4% | 370,300 |
| 2018/04/25 | 7,880 | 8,050 | 7,870 | 8,030 | +180 | +2.3% | 374,600 |
| 2018/04/24 | 8,240 | 8,260 | 7,810 | 7,850 | -390 | -4.7% | 498,000 |
| 2018/04/23 | 8,340 | 8,350 | 8,090 | 8,240 | -240 | -2.8% | 287,100 |
| 2018/04/20 | 8,090 | 8,490 | 8,080 | 8,480 | +390 | +4.8% | 600,000 |
| 2018/04/19 | 8,040 | 8,250 | 7,970 | 8,090 | +280 | +3.6% | 548,000 |
| 2018/04/18 | 7,560 | 7,840 | 7,430 | 7,810 | +250 | +3.3% | 320,200 |
| 2018/04/17 | 7,540 | 7,630 | 7,520 | 7,560 | -10 | -0.1% | 183,700 |
| 2018/04/16 | 7,270 | 7,580 | 7,250 | 7,570 | +370 | +5.1% | 279,300 |
| 2018/04/13 | 7,350 | 7,390 | 7,140 | 7,200 | -90 | -1.2% | 208,800 |
| 2018/04/12 | 7,210 | 7,330 | 7,210 | 7,290 | +150 | +2.1% | 225,800 |
| 2018/04/11 | 7,330 | 7,350 | 7,120 | 7,140 | -270 | -3.6% | 328,300 |
| 2018/04/10 | 7,600 | 7,600 | 7,390 | 7,410 | -100 | -1.3% | 206,700 |
| 2018/04/09 | 7,430 | 7,560 | 7,390 | 7,510 | +80 | +1.1% | 240,300 |
| 2018/04/06 | 7,490 | 7,570 | 7,410 | 7,430 | -70 | -0.9% | 246,000 |
| 2018/04/05 | 7,350 | 7,540 | 7,330 | 7,500 | +230 | +3.2% | 261,000 |
| 2018/04/04 | 7,280 | 7,310 | 7,210 | 7,270 | -10 | -0.1% | 160,500 |
| 2018/04/03 | 6,970 | 7,320 | 6,950 | 7,280 | +220 | +3.1% | 339,800 |
| 2018/04/02 | 7,230 | 7,290 | 7,060 | 7,060 | -60 | -0.8% | 166,900 |
| 2018/03/30 | 7,200 | 7,210 | 7,070 | 7,120 | -20 | -0.3% | 179,400 |
| 2018/03/29 | 7,070 | 7,170 | 6,930 | 7,140 | +40 | +0.6% | 263,700 |
| 2018/03/28 | 7,120 | 7,180 | 7,050 | 7,100 | -110 | -1.5% | 211,600 |
| 2018/03/27 | 7,250 | 7,300 | 7,150 | 7,210 | +20 | +0.3% | 298,600 |
| 2018/03/26 | 6,870 | 7,190 | 6,870 | 7,190 | +370 | +5.4% | 453,400 |
| 2018/03/23 | 6,800 | 6,920 | 6,790 | 6,820 | -120 | -1.7% | 378,300 |
| 2018/03/22 | 6,870 | 6,960 | 6,800 | 6,940 | -30 | -0.4% | 412,400 |
| 2018/03/20 | 7,080 | 7,080 | 6,900 | 6,970 | +80 | +1.2% | 370,500 |
| 2018/03/19 | 6,950 | 6,970 | 6,780 | 6,890 | -170 | -2.4% | 313,700 |
| 2018/03/16 | 6,950 | 7,090 | 6,900 | 7,060 | +210 | +3.1% | 603,000 |
| 2018/03/15 | 6,870 | 6,960 | 6,830 | 6,850 | +50 | +0.7% | 359,700 |
| 2018/03/14 | 6,750 | 6,850 | 6,700 | 6,800 | +20 | +0.3% | 363,500 |
| 2018/03/13 | 6,690 | 6,790 | 6,670 | 6,780 | +50 | +0.7% | 256,800 |
| 2018/03/12 | 6,700 | 6,810 | 6,690 | 6,730 | +130 | +2% | 351,600 |
| 2018/03/09 | 6,710 | 6,710 | 6,590 | 6,600 | +90 | +1.4% | 524,900 |
| 2018/03/08 | 6,470 | 6,530 | 6,400 | 6,510 | +140 | +2.2% | 481,600 |
| 2018/03/07 | 6,140 | 6,400 | 6,130 | 6,370 | +170 | +2.7% | 535,700 |
| 2018/03/06 | 6,200 | 6,240 | 6,150 | 6,200 | +60 | +1% | 464,600 |
| 2018/03/05 | 5,940 | 6,170 | 5,930 | 6,140 | +160 | +2.7% | 577,800 |
1701～
1750
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
